GPX1 and chronic obstructive pulmonary disease: The identification of GPx-1 as a potential biomarker of oxidative stress in COPD warrants longitudinal studies to determine its prognostic role in terms of disease progression and mortality, and to investigate the effects of specific antioxidant therapies in these patients.